|
Blank fields on this form indicate the information is unchanged, unknown or unavailable.D10 ¿ product received on: 27aug2020.Investigation ¿ evaluation.Piedmont fayette hospital in the united states informed cook of an incident involving three ultrathane cope nephroureterectomy sets that were from the same procedure performed on (b)(6) 2020.All devices were for difficult removal of the blue flexible stiffener.Two were used in the patient and are reported under medwatch report #1820334-2020-01581.One device was prior to patient contact and will be captured in this report.For the prior to use device, the stiffener could not be removed prior to patient contact.All surfaces of the devices were wetted and a larger cook nephroureterectomy device (10 fr) was used to complete the procedure.No unintended section of the device remained inside the patient¿s body, the patient did not require additional procedures due to this occurrence and there have been no adverse effects to the patient due to this occurrence.A review of the complaint history, device history record, drawing, instructions for use (ifu), manufacturing instructions, quality control, and specifications of the device, as well as a visual inspection and dimensional verification, were conducted during the investigation.The complainant returned one device to cook for investigation.One 8.5fr catheter was returned with the flexible stiffener inserted inside the catheter.There is no biomatter present.The flexible stiffener was approximately 4cm from exiting the proximal end of catheter.The stiffener could not be advanced to the tip of catheter.However, with slight force, the stiffener was removed from the catheter.There is no damage to either the catheter or stiffener.The inner diameter of the catheter and the outer diameter of the flexible stiffener were measured to be within specification.Additionally, a document-based investigation evaluation was performed.The risks associated with these devices are acceptable when weighed against the benefits.Sufficient inspection activities are in place to identify this failure mode prior to distribution.The product label and instructions for use (ifu) were reviewed for relevant information for reported failure mode.Relevant information for failure mode includes: precautions: "activate hydrophilic coating, if present, by wetting surface of device with sterile water or saline.For best results, maintain wetted condition of device during placement." instructions for use: stent placement "1.Using standard percutaneous access technique, establish wire guide position well into the bladder.5.Over the wire guide, introduce the stent/stiffening cannula into the kidney collecting system.6.After establishing proper proximal and distal position, push the stent off the stiffening cannula over the wire, making sure the distal pigtail forms within the bladder.7.Remove the stiffening cannula from the stent, leaving the wire guide in place.¿ the device history record (dhr) was reviewed for final lot, sub assembly lot, and raw material lot.Cook concluded that there were no relevant non-conformances related to this incident.Additionally, a complaint database search was completed.No additional complaints were found.As there are adequate inspection activities established, objective evidence that the dhr was fully executed, no related non-conformances and no additional complaints from the same lot, it was concluded that there is no evidence that nonconforming product exists in house or in field.The customer reported there was difficulty removing the stiffener.Upon return of the complaint device, there was slight difficulty removing the stiffener, but it could be removed.Based on the information provided, examination of the returned products, and the results of the investigation, a definitive root cause could not be established.A capa has been opened to address both difficult advancement and removal of the stiffener and is currently undergoing investigation.The appropriate personnel have been notified.Per the quality engineering risk assessment, no further action is required.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|